A group of researchers from the Royal Melbourne Hospital and Peter MacCallum Cancer Centre are investigating a nasal spray option to prevent respiratory viral infections, such as COVID-19 and the flu. 

Person using nasal spray

With over 145 participants currently enrolled in the trial, the C-SMART study has been designed specifically for people diagnosed with cancer.

Find out more about C-SMART.

Mobile Stroke Unit with Ambulance Victoria paramedic and the RMH Stroke team
Media enquiries

We provide a media service from 6am to 10pm each day. Journalists are welcome to contact our media advisor on-call via the RMH Switchboard on (03) 9342 7000.

During business hours, journalists can email mh-communications@mh.org.au. We do not respond to emails outside business hours.